These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7719440

  • 1. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria.
    Chang TM, Bourget L, Lister C.
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(1):1-21. PubMed ID: 7719440
    [Abstract] [Full Text] [Related]

  • 2. Effects of oral administration of artificial cells immobilized phenylalanine ammonia-lyase on intestinal amino acids of phenylketonuric rats.
    Bourget L, Chang TM.
    Biomater Artif Cells Artif Organs; 1989; 17(2):161-81. PubMed ID: 2775877
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
    Sarkissian CN, Gámez A.
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
    [Abstract] [Full Text] [Related]

  • 5. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase.
    Sarkissian CN, Shao Z, Blain F, Peevers R, Su H, Heft R, Chang TM, Scriver CR.
    Proc Natl Acad Sci U S A; 1999 Mar 02; 96(5):2339-44. PubMed ID: 10051643
    [Abstract] [Full Text] [Related]

  • 6. Phenylalanine ammonia lyase (PAL): From discovery to enzyme substitution therapy for phenylketonuria.
    Levy HL, Sarkissian CN, Scriver CR.
    Mol Genet Metab; 2018 Aug 02; 124(4):223-229. PubMed ID: 29941359
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU.
    Durrer KE, Allen MS, Hunt von Herbing I.
    PLoS One; 2017 Aug 02; 12(5):e0176286. PubMed ID: 28520731
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.
    Sarkissian CN, Kang TS, Gámez A, Scriver CR, Stevens RC.
    Mol Genet Metab; 2011 Nov 02; 104(3):249-54. PubMed ID: 21803624
    [Abstract] [Full Text] [Related]

  • 10. Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM).
    Thomas J, Levy H, Amato S, Vockley J, Zori R, Dimmock D, Harding CO, Bilder DA, Weng HH, Olbertz J, Merilainen M, Jiang J, Larimore K, Gupta S, Gu Z, Northrup H, PRISM investigators.
    Mol Genet Metab; 2018 May 02; 124(1):27-38. PubMed ID: 29653686
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.
    Bell SM, Wendt DJ, Zhang Y, Taylor TW, Long S, Tsuruda L, Zhao B, Laipis P, Fitzpatrick PA.
    PLoS One; 2017 May 02; 12(3):e0173269. PubMed ID: 28282402
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Optimising amino acid absorption: essential to improve nitrogen balance and metabolic control in phenylketonuria.
    MacDonald A, Singh RH, Rocha JC, van Spronsen FJ.
    Nutr Res Rev; 2019 Jun 02; 32(1):70-78. PubMed ID: 30284526
    [Abstract] [Full Text] [Related]

  • 15. Preliminary Investigation of Microbiome and Dietary Differences in Patients with Phenylketonuria on Enzyme Substitution Therapy Compared to Traditional Therapies.
    McWhorter N, Dhillon J, Hoffman J.
    J Acad Nutr Diet; 2022 Jul 02; 122(7):1283-1295.e3. PubMed ID: 34968752
    [Abstract] [Full Text] [Related]

  • 16. [Phenylketonuria: new treatments].
    Feillet F, Bonnemains C.
    Arch Pediatr; 2013 Oct 02; 20(10):1165-8. PubMed ID: 23910161
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Alternative therapies to address the unmet medical needs of patients with phenylketonuria.
    Blau N, Longo N.
    Expert Opin Pharmacother; 2015 Apr 02; 16(6):791-800. PubMed ID: 25660215
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.